Randomized, Placebo-Controlled, Crossover Study of Methylphenidate for Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers with Developmental Disorders-Reference-Cited by-同舟云学术

Randomized, Placebo-Controlled, Crossover Study of Methylphenidate for Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers with Developmental Disorders

Published:2009-08 Issue:4 Volume:19 Page:329-339
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Ghuman Jaswinder K.¹,Aman Michael G.²,Lecavalier Luc²,Riddle Mark A.³,Gelenberg Alan¹⁴,Wright Ron¹,Rice Sydney⁵,Ghuman Harinder S.¹,Fort Carolyn¹

Affiliation:

1. University of Arizona, Child and Adolescent Psychiatry, Tucson, Arizona.

2. Nisonger Center, Ohio State University, Columbus, Ohio.

3. Johns Hopkins University, Division of Child and Adolescent Psychiatry, Baltimore, Maryland.

4. Present address: Healthcare Technology Systems, Madison, Wisconsin.

5. University of Arizona, Department of Pediatrics, Tucson, Arizona.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2008.0137

Reference35 articles.

1. Psychotropic and Anticonvulsant Drugs in Subjects with Autism: Prevalence and Patterns of Use

2. The Nisonger CBRF: A child behavior rating form for children with developmental disabilities

3. Methylphenidate Treatment in Children with Borderline IQ and Mental Retardation: Analysis of Three Aggregated Studies

4. Medication Patterns in Patients with Autism: Temporal, Regional, and Demographic Influences

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness of pharmacological interventions for managing ADHD symptoms in individuals with autism spectrum disorder: A systematic review and meta-analysis;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-08

2. Neurodevelopmental Disorders: Autism Spectrum Disorder;Tasman’s Psychiatry;2024

3. Therapeutic Use of Dopamine Enhancers (Stimulants);Tasman’s Psychiatry;2024

4. Pharmacotherapy of Behavioral Symptoms and Psychiatric Comorbidities in Adolescents and Adults with Autism Spectrum Disorders;Adolescents and Adults with Autism Spectrum Disorders;2024

5. Efficacy and tolerability of psychostimulants for symptoms of attention-deficit hyperactivity disorder in preschool children: A systematic review and meta-analysis;European Psychiatry;2023